Outcomes for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the elderly

Keyphrases

• Cytoreductive Surgery 100%
• Hyperthermic Intraperitoneal Chemotherapy (HIPEC) 100%
• Peritoneal Carcinomatosis 100%
• Mortality Rate 50%
• Major Morbidity 50%
• Morbidity Rate 50%
• Appendiceal 50%
• Multivariate Analysis 25%
• Median Survival 25%
• Consecutive Patients 25%
• Tertiary Care Hospital 25%
• Operative Time 25%
• Perioperative Morbidity 25%
• Postoperative Mortality 25%
• Tumor Subtype 25%
• Patient Selection 25%
• Perioperative Blood Transfusion 25%
• Estimated Blood Loss 25%
• Timing of Surgery 25%
• Recurrence Rate 25%
• Colorectal Cancer 25%
• Non-associated 25%
• Univariate Analysis 25%
• Young Subgroup 25%
• Mitomycin C 25%
• Tumor Site 25%
• Postoperative Outcomes 25%
• Bowel Anastomosis 25%
• Surgery Groups 25%
• Cytoreduction 25%
• Carcinomatosis 25%
• Optimal Cytoreduction 25%
• Appendiceal Cancer 25%

Medicine and Dentistry

• Cytoreductive Surgery 100%
• Hyperthermic Intraperitoneal Chemotherapy 100%
• Carcinomatous Peritonitis 100%
• Intraperitoneal Chemotherapy 75%
• Neoplasm 50%
• Percutaneous Coronary Intervention 50%
• Mortality Rate 50%
• Morbidity 50%
• Malignant Neoplasm 25%
• Bleeding 25%
• Operation Duration 25%
• Multivariate Analysis 25%
• Blood Transfusion 25%
• Surgical Anastomosis 25%
• Recurrence Risk 25%
• Univariate Analysis 25%
• Mitomycin 25%
• Carcinosis 25%